Concepedia

James Wild

JW

Statistics

Publications

11

Citations

691

H-Index

10

Active since

1999

Affiliations

Williams (United States)(Current)

AMC Neurology Group Clinical Research Center

Clinical Research Associates

Shionogi (United States)

PRA Health Sciences

James Wild is an author at Williams (United States) specializing in pharmacotherapy, opioid therapy, and pain medicine.

Publications per year

1999–2021

11

Publications

11

Long-term Safety and Tolerability of Tapentadol Extended Release for the Management of Chronic Low Back Pain or Osteoarthritis Pain

James Wild, Stefan Grond, Brigitte Kuperwasser et al. · Pain Practice · 2010 · 181 citations

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Controlled-Release Versus Immediate-Release Oxycodone: Randomized, Double-Blind Evaluation in Patients with Chronic Back Pain

M. Hale, Roy Fleischmann, Robert T. Salzman et al. · Clinical Journal of Pain · 1999 · 134 citations

Medicine, Pharmacotherapy, Pain Management +16

Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials

M. Hale, James Wild, Jyotsna Reddy et al. · The Lancet. Gastroenterology & hepatology · 2017 · 129 citations

Medicine, Pharmacology, Pharmacotherapy +12

Can a Controlled-Release Oral Dose Form of Oxycodone Be Used as Readily as an Immediate-Release Form for the Purpose of Titrating to Stable Pain Control?

Robert T. Salzman, Michael S. Roberts, James Wild et al. · Journal of Pain and Symptom Management · 1999 · 109 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Single-Entity Hydrocodone Extended-Release Capsules in Opioid-Tolerant Subjects with Moderate-to-Severe Chronic Low Back Pain: A Randomized Double-Blind, Placebo-Controlled Study

Richard Rauck, Srinivas Nalamachu, James Wild et al. · Pain Medicine · 2014 · 51 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 11